Literature DB >> 17476471

[Prevalence of chronic tympanic membrane perforation in the adult population].

H Kaftan1, M Noack, N Friedrich, H Völzke, W Hosemann.   

Abstract

BACKGROUND: The goal of this study was to evaluate the prevalence of chronic tympanic membrane perforation in the adult population. MATERIALS AND
METHOD: The study population included 1,000 subjects (453 males, 547 females) aged 18-93 years. In addition to interview data, ear examinations were performed.
RESULTS: There were eight subjects with unilateral chronic tympanic membrane perforation and a single subject with a bilateral perforation. The age adjusted prevalence of chronic tympanic membrane perforation was 0.45% (95% confidence interval: 0.03-0.87). Eight out of nine subjects disliked tympanoplasty.
CONCLUSION: The high proportion of subjects with chronic tympanic membrane perforations who do not want to be operated suggests that there is a considerable need for novel therapeutic procedures.

Mesh:

Year:  2008        PMID: 17476471     DOI: 10.1007/s00106-007-1574-0

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  16 in total

1.  An observational study of the management of traumatic tympanic membrane perforations.

Authors:  J E O Amadasun
Journal:  J Laryngol Otol       Date:  2002-03       Impact factor: 1.469

2.  [An improved animal model for chronic perforation of the tympanic membrane].

Authors:  H Kaftan; W Hosemann; A Beule; D Junghans
Journal:  HNO       Date:  2004-08       Impact factor: 1.284

3.  The aging ear: an otomicroscopic and tympanometric study.

Authors:  Niels Christian Stenklev; Ole Vik; Einar Laukli
Journal:  Acta Otolaryngol       Date:  2004-01       Impact factor: 1.494

4.  [Fibrin gel for treatment of tympanic membrane perforations: an experimental animal model].

Authors:  H Kaftan; D Eyrich; E Schindler; A Göpferich; W Hosemann
Journal:  HNO       Date:  2006-12       Impact factor: 1.284

5.  Interexaminer reliability of otoscopic signs and tympanometric measures for older adults.

Authors:  D M Nondahl; K J Cruickshanks; T L Wiley; T S Tweed; B E Klein; R Klein
Journal:  J Am Acad Audiol       Date:  1996-08       Impact factor: 1.664

6.  Induction of growth factor expression is reduced during healing of tympanic membrane perforations in glucocorticoid-treated rats.

Authors:  Shin-ichi Ishimoto; Toshio Ishibashi
Journal:  Ann Otol Rhinol Laryngol       Date:  2002-10       Impact factor: 1.547

7.  Myringoplasty: does the size of the perforation matter?

Authors:  P Lee; G Kelly; R P Mills
Journal:  Clin Otolaryngol Allied Sci       Date:  2002-10

Review 8.  [Reconstruction of the tympanic membrane applying cartilage: indications, techniques and results].

Authors:  A Neumann; K Jahnke
Journal:  HNO       Date:  2005-06       Impact factor: 1.284

9.  The prevalence of middle ear disease in the adult British population.

Authors:  G G Browning; S Gatehouse
Journal:  Clin Otolaryngol Allied Sci       Date:  1992-08

10.  [Traumatic tympanic membrane perforactions. Local application of an alginate matrix loaded with epidermal growth factor in an animal model].

Authors:  H Kaftan; W Hosemann; D Junghans; A Göpferich; E Schindler; A Beule
Journal:  HNO       Date:  2005-06       Impact factor: 1.284

View more
  3 in total

1.  Otoscope fogging: examination finding for perforated tympanic membrane.

Authors:  Jason F Naylor
Journal:  BMJ Case Rep       Date:  2014-05-30

2.  High-Frequency Conductive Hearing following Total Drum Replacement Tympanoplasty.

Authors:  Marc D Polanik; Danielle R Trakimas; Nicole L Black; Jeffrey T Cheng; Elliott D Kozin; Aaron K Remenschneider
Journal:  Otolaryngol Head Neck Surg       Date:  2020-02-25       Impact factor: 3.497

3.  Impact of depressive disorders on quality of life after middle ear surgery in patients with chronic otitis media.

Authors:  Susen Lailach; Theresa Langanke; Thomas Zahnert; Susan Garthus-Niegel; Marcus Neudert
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-10-03       Impact factor: 2.503

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.